Mikacin Inj 750

MIKACIN INJ 750

Name

• Common Name: Amikacin
• Brand Name: Mikacin 750mg Injection
• Manufacturer: Aristo Pharmaceuticals Pvt Ltd.

Composition

• Active Ingredient: Amikacin Sulphate 750mg.
• Mikacin 750mg Injection contains Amikacin, which belongs to the class of Aminoglycoside Antibiotics.

Uses

Mikacin 750mg Injection is a powerful antibiotic primarily used to treat and prevent a diverse range of severe bacterial infections susceptible to amikacin. These infections can affect various parts of the body, including:

• Urinary tract
• Bones and joints
• Lungs (such as pneumonia and respiratory tract infections)
• Brain (including meningitis)
• Blood (septicemia/bloodstream infections)
• Intra-abdominal infections
• Skin and soft tissue infections, including infected burns
• Gastrointestinal infections It is also used prophylactically in high-risk hospitalized patients to prevent infections. Mikacin works by inhibiting the production of essential bacterial proteins, leading to bacterial cell death.

Dosage and Administration

Mikacin 750mg Injection is administered by a healthcare professional via intravenous infusion (drip) or direct injection into a vein or muscle. Self-administration is not recommended.

• Adults with normal renal function: Typically 15 mg/kg/day, divided into 2 or 3 equal doses, or as a single daily dose, with a maximum of 1.0 g/day.
• Adults above 59 years: The dose may be reduced to 10 mg/kg per day (750 mg).
• Children: Max dose of 15-30 mg/kg/day (1 g/day) as a single daily dose, or 15-20 mg/kg once daily, or 7.5 mg/kg every 12 hours.
• Neonates: Initial dose of 10 mg/kg, followed by 7.5 mg/kg every 12 hours.
• Premature infants: Recommended dosing is 7.5 mg/kg every 12 hours. Dosage and frequency are determined by the doctor based on the infection's severity, patient's kidney function, age, and weight. It is crucial to complete the full course of treatment, even if symptoms improve, to prevent the infection from returning or worsening. Regular monitoring of kidney function, hearing, and blood levels of the medication may be conducted during treatment.

Side Effects

Common Side Effects:

• Injection site reactions (pain, swelling, redness)
• Increased blood urea levels
• Nausea, vomiting, rash
• Tinnitus (ringing in the ears), hearing problems, inner ear damage
• Kidney problems (changes in urination, difficulty sleeping, loss of appetite)
• Changes in blood cell levels, low magnesium levels
• Tremors, sensory disturbances, headaches, dizziness, balance disorders

Serious Side Effects (Seek immediate medical attention if experienced):

• Persisting ringing in the ears, decrease in urine production, severe kidney failure
• Severe allergic reactions (itchy rash/hives, swelling of feet, ankles, hands, face, lips, mouth or throat, difficulty swallowing or breathing, feeling of faintness)
• Paralysis, deafness or sudden loss of hearing, sudden loss of breathing
• Vision disturbances, changes in the retina of the eye, low blood pressure, inflammation of vein walls, itching, joint pain, muscle twitching, fever, liver function changes

Precautions

• Contraindications: Do not use if allergic to amikacin, other aminoglycoside antibiotics, or sulphites. It is also contraindicated in individuals with myasthenia gravis (severe muscle weakness).
• Kidney and Hearing Impairment: Use with extreme caution in patients with existing kidney problems, hearing difficulties (tinnitus), or a history of antibiotic-related hearing loss.
• Pregnancy and Breastfeeding: Use with caution during pregnancy (Category D: positive evidence of human fetal risk, use only if potential benefits outweigh risks) and breastfeeding (not known if excreted into breast milk). Consult a doctor.
• Elderly and Infants: Elderly patients (above 60 years) and premature or newborn infants should use this medication with caution, often requiring dose adjustments.
• Monitoring: Regular monitoring of kidney function, hearing assessments, and blood levels of the medication are vital throughout treatment.
• Hydration: Patients should remain well-hydrated during treatment.
• Driving and Machinery: Mikacin may cause dizziness; therefore, caution is advised when driving or operating heavy machinery.
• Alcohol: It is generally not recommended to consume alcohol as it can interact with the medication, increase side effects, or reduce effectiveness.
• Drug Interactions: Inform your doctor about all medications, supplements, or herbal products being taken, especially other antibiotics, immunosuppressants, diuretics (water pills), and muscle relaxants, to avoid potential interactions.

Storage

Store Mikacin 750mg Injection in a cool, dry place away from direct sunlight, at temperatures below 25°C or below 30°C. Keep it out of the sight and reach of children. Unused portions of opened vials should not be stored for later use.

Here are frequently asked questions about MIKACIN INJ 750 (Amikacin 750mg Injection):

1. What is MIKACIN INJ 750 used for?

MIKACIN INJ 750 is a powerful antibiotic primarily used to treat severe bacterial infections. These can include infections of the urinary tract, bones, joints, lungs (such as pneumonia), brain (like meningitis), bloodstream (septicemia), intra-abdominal infections, and skin and soft tissue infections, including infected burns. It is also used to prevent infections in high-risk hospitalized patients.

2. How does MIKACIN INJ 750 work?

MIKACIN INJ 750 contains Amikacin, which belongs to the aminoglycoside class of antibiotics. It works by binding to the 30S ribosomal subunit in susceptible bacteria, interfering with their protein synthesis. This disruption leads to faulty or halted protein production, ultimately causing bacterial cell death and stopping the spread of infection.

3. What is the usual dosage of MIKACIN INJ 750?

The dosage of MIKACIN INJ 750 is determined by a healthcare professional based on factors such as your body weight, age, and the severity of the infection. For adults with normal kidney function, the recommended intramuscular dosage is typically 15 mg/kg per day, often given as a single daily dose, 5-7 days a week, with a maximum daily dose of 1.0 g/day. For elderly patients (over 59 years), the dose may be reduced to 10 mg/kg per day (750 mg). MIKACIN INJ 750 is administered as an intravenous infusion or injection by a healthcare professional; it should not be self-administered.

4. What are the possible side effects of MIKACIN INJ 750?

Common side effects can include reactions at the injection site (pain, swelling, redness), increased blood urea levels, nausea, vomiting, rash, and tinnitus (ringing in the ears). More serious side effects, particularly with high doses, may involve hearing problems, inner ear damage, balance disorders, and kidney issues such as changes in urination or decreased urine output. Rarely, severe allergic reactions, vision disturbances, paralysis, deafness, or breathing difficulties can occur.

5. Is MIKACIN INJ 750 safe during pregnancy or breastfeeding?

MIKACIN INJ 750 is generally not recommended during pregnancy (Pregnancy Category D) and should only be used if considered absolutely necessary and if the potential benefits outweigh the risks, as it may be unsafe. For breastfeeding mothers, it is not known if Amikacin passes into breast milk. Caution is advised, and you should consult your doctor to determine whether to discontinue breastfeeding or the treatment.

6. Can MIKACIN INJ 750 be taken with other medications?

MIKACIN INJ 750 can interact with certain medications. It should be used with caution or avoided with other drugs that can cause kidney damage or hearing problems (neurotoxic or nephrotoxic agents) such as cisplatin, vancomycin, polymyxin B, cyclosporine, tacrolimus, or other aminoglycosides, as this increases the risk of side effects. Potent diuretics like furosemide and ethacrynic acid can also increase the risk of hearing issues. Additionally, some beta-lactam antibiotics (e.g., penicillin, cephalosporins) may have reduced effectiveness when used concurrently. Inform your doctor about all other medications you are currently taking.

7. What precautions should be taken with MIKACIN INJ 750?

Before receiving MIKACIN INJ 750, inform your doctor if you have kidney problems, hearing difficulties, a history of antibiotic-related hearing loss, or mitochondrial mutation diseases. It is not recommended for individuals with conditions like myasthenia gravis or Parkinson's disease. Elderly patients (over 60 years) should use it with caution, and dosage adjustments may be required. Regular monitoring through kidney function tests, hearing assessments, and urine tests is crucial during treatment. Ensure you stay well-hydrated throughout the treatment.

8. What happens if a dose of MIKACIN INJ 750 is missed?

Since MIKACIN INJ 750 is administered by a doctor or nurse in a healthcare setting, missing a dose is unlikely. If you believe a dose was missed, inform your doctor or nurse immediately, and they will advise on the appropriate course of action. Do not attempt to make up for a missed dose on your own.

9. How should MIKACIN INJ 750 be stored?

MIKACIN INJ 750 should be stored in a cool and dry place, away from direct sunlight and moisture. It should be kept out of the reach of children. Some recommendations specify storing it below 25°C or 30°C.